OKAY
833230
CHANGFU CO.,LTD
871396
CHENGUANG MEDICAL
430300
4
Gansu Longshenrongfa Pharmaceutical Industry
300534
5
Tibet Duo Rui Pharmaceutical
301075
CN Stock MarketDetailed Quotes
002162 Everjoy Health Group
- 4.10
- 0.000.00%
Noon Break Apr 1 11:30 CST
3.78BMarket Cap-25.63P/E (TTM)
4.15High4.10Low146.93KlotVolume4.10Open4.10Pre Close60.66MTurnover1.60%Turnover RatioLossP/E (Static)921.58MShares5.7652wk High4.57P/B3.77BFloat Cap2.5552wk Low4.51Limit Up920.70MShs Float13.98Historical High3.69Limit Down1.22%Amplitude1.40Historical Low--Dividend TTM4.13Avg Price69.54KlotAsk--Div YieldTTM100Lot Size73.86KlotBid
Everjoy Health Group Key Stats
All
YOY
| (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | -8.54%1.26B | -8.57%921.78M | -10.14%556.01M | -11.21%227.78M | 9.32%1.37B | 12.17%1.01B | 19.70%618.75M | 17.94%256.53M | -5.35%1.26B | -4.03%898.84M |
| Refunds of taxes and levies | --408.76K | 20,297.24%1.73M | 17,366.54%1.48M | ---- | ---- | -99.60%8.5K | -99.58%8.5K | -99.37%8.48K | 720.00%14.02M | 777.37%2.15M |
| Cash received relating to other operating activities | 88.13%44.79M | 46.65%113.64M | 84.13%66.36M | -18.55%37.95M | 132.19%23.81M | 3.26%77.49M | 45.83%36.04M | 16.44%46.6M | -72.69%10.25M | 19.34%75.05M |
| Cash inflows from operating activities | -6.86%1.3B | -4.47%1.04B | -4.72%623.86M | -12.34%265.73M | 9.11%1.4B | 11.23%1.09B | 20.44%654.79M | 17.10%303.14M | -6.30%1.28B | -2.37%976.04M |
| Goods services cash paid | -1.90%888.57M | 2.56%745.37M | 5.75%485.69M | -4.34%224.47M | 7.87%905.8M | 12.15%726.77M | 14.35%459.26M | 30.15%234.66M | 4.22%839.73M | 8.65%648.03M |
| Staff behalf paid | 1.71%209.47M | 4.32%164.01M | 2.78%111.17M | 3.13%55.43M | 1.25%205.94M | 3.04%157.22M | 6.05%108.17M | -4.66%53.75M | -4.02%203.41M | -6.70%152.58M |
| All taxes paid | -42.58%42.69M | -53.89%26.15M | -60.01%12.88M | 27.20%8.47M | 20.21%74.35M | 31.64%56.71M | 18.27%32.2M | -23.73%6.66M | -15.78%61.85M | -17.04%43.08M |
| Cash paid relating to other operating activities | -10.45%77.75M | -25.28%68.11M | -18.94%33.46M | -39.45%31.33M | -41.77%86.83M | -44.73%91.16M | 20.78%41.28M | -53.66%51.74M | 22.57%149.12M | -19.86%164.93M |
| Cash outflows from operating activities | -4.28%1.22B | -2.73%1B | 0.36%643.2M | -7.82%319.71M | 1.50%1.27B | 2.30%1.03B | 13.43%640.92M | -2.87%346.81M | 3.41%1.25B | -0.89%1.01B |
| Net cash flows from operating activities | -33.48%82.23M | -37.73%33.52M | -239.46%-19.35M | -23.59%-53.98M | 377.71%123.62M | 265.19%53.83M | 164.97%13.87M | 55.51%-43.67M | -83.11%25.88M | -81.10%-32.58M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | 21.60%154.55M | -33.77%110.26M | -47.74%87M | 84.00%46M | 2.86%127.1M | 65.54%166.48M | 65.54%166.48M | -75.14%25M | -79.99%123.57M | -74.60%100.57M |
| Cash received from returns on investments | -49.73%5.27M | -77.28%1.66M | -99.23%56.39K | -99.56%25.13K | 40.22%10.49M | -2.36%7.29M | 242.35%7.29M | 168.94%5.72M | 24.99%7.48M | 27.33%7.46M |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | -99.99%2.73K | ---- | ---- | ---- | 206.29%20.74M | --20.74M | --20.69M | --20.65M | -37.76%6.77M | ---- |
| Net cash received from disposal of subsidiaries and other business units | -54.52%39.37M | ---- | ---- | ---- | --86.58M | --7.2M | --7.2M | --3.7M | ---- | ---- |
| Cash inflows from investing activities | -18.66%199.2M | -44.52%111.91M | -56.83%87.06M | -16.42%46.03M | 77.70%244.9M | 86.71%201.7M | 96.36%201.66M | -46.38%55.07M | -78.32%137.82M | -73.52%108.03M |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -36.14%31.62M | -18.45%27.89M | -37.08%16.74M | -37.97%8.24M | 25.35%49.52M | 0.43%34.19M | 2.01%26.61M | -17.76%13.29M | 15.65%39.5M | 18.47%34.05M |
| Cash paid to acquire investments | 53.59%176.63M | 1.50%88.3M | 0.57%87.5M | 5.08%46.5M | -36.85%115M | -42.80%87M | -33.30%87M | -55.94%44.25M | -72.34%182.09M | -61.60%152.09M |
| Net cash paid to acquire subsidiaries and other business units | ---- | ---- | ---- | ---- | ---- | --12.9M | --7.68M | --1.44M | ---- | ---- |
| Cash paid relating to other investing activities | ---- | --90M | --20M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash outflows from investing activities | 26.59%208.26M | 53.76%206.19M | 2.43%124.24M | -7.18%54.74M | -25.76%164.52M | -27.96%134.09M | -22.51%121.29M | -49.41%58.98M | -68.00%221.6M | -57.27%186.14M |
| Net cash flows from investing activities | -111.27%-9.06M | -239.44%-94.28M | -146.27%-37.19M | -122.80%-8.72M | 195.95%80.39M | 186.56%67.61M | 249.33%80.37M | 71.84%-3.91M | -47.62%-83.78M | -182.48%-78.11M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | -89.96%1.58M | -93.48%1.03M | -93.48%1.03M | ---- | --15.75M | --15.75M | --15.75M | --35M | ---- | ---- |
| -Including: Cash received from capital contributions by minority shareholders of subsidiaries | ---- | ---- | ---- | ---- | --15.75M | ---- | ---- | ---- | ---- | ---- |
| Cash from borrowing | 6.11%339.54M | 37.56%309.52M | 3.14%165.02M | -14.98%85.02M | -56.98%320M | -65.09%225M | -40.20%160M | 47.16%100M | 65.60%743.75M | 82.99%644.56M |
| Cash received relating to other financing activities | -44.01%30M | -73.49%15M | -81.34%10M | -65.01%10M | 45.94%53.58M | 2,543.86%56.59M | 2,403.15%53.58M | --28.58M | --36.71M | --2.14M |
| Cash inflows from financing activities | -4.68%371.12M | 9.49%325.55M | -23.23%176.05M | -41.91%95.02M | -50.12%389.33M | -54.02%297.34M | -14.97%229.33M | 140.73%163.58M | 20.63%780.47M | 17.55%646.71M |
| Borrowing repayment | -19.68%355M | -35.38%242.35M | -46.74%128.5M | 14.77%88.75M | -37.78%441.97M | -40.79%375.03M | -7.31%241.28M | -10.96%77.33M | 40.30%710.34M | 67.76%633.36M |
| Dividend interest payment | -3.19%23.72M | -1.92%19.24M | -6.12%13M | -10.86%7.56M | 3.74%24.51M | -1.48%19.61M | -0.74%13.85M | 56.70%8.49M | -19.69%23.62M | -26.82%19.91M |
| -Including:Cash payments for dividends or profit to minority shareholders | ---- | ---- | ---- | --1.8M | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash payments relating to other financing activities | 157.93%135.46M | 109.45%51.48M | 169.51%40.98M | 93.17%10.69M | -45.95%52.52M | 109.42%24.58M | 71.13%15.21M | -59.09%5.53M | -17.02%97.16M | -89.56%11.74M |
| Cash outflows from financing activities | -0.93%514.18M | -25.32%313.07M | -32.50%182.49M | 17.14%107M | -37.56%518.99M | -36.96%419.22M | -4.53%270.34M | -13.65%91.35M | 27.32%831.12M | 28.58%665M |
| Net cash flows from financing activities | -10.34%-143.06M | 110.24%12.48M | 84.30%-6.44M | -116.59%-11.98M | -156.00%-129.66M | -566.04%-121.88M | -204.62%-41.01M | 290.91%72.23M | -775.65%-50.65M | -155.53%-18.3M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | -86.61%2.75K | -102.84%-794.27 | -87.96%3.94K | 108.00%889.33 | -80.77%20.54K | -80.39%27.94K | -39.31%32.74K | 39.33%-11.11K | 312.19%106.85K | 688.41%142.49K |
| Net increase in cash and cash equivalents | -193.98%-69.89M | -11,522.62%-48.28M | -218.21%-62.97M | -403.17%-74.68M | 168.58%74.36M | 99.68%-415.41K | 160.13%53.27M | 116.43%24.63M | -219.61%-108.44M | -913.43%-128.85M |
| Add:Begin period cash and cash equivalents | 52.68%215.53M | 52.68%215.53M | 52.68%215.53M | 52.68%215.53M | -43.44%141.17M | -43.44%141.17M | -43.44%141.17M | -43.44%141.17M | 57.04%249.61M | 57.04%249.61M |
| End period cash equivalent | -32.42%145.65M | 18.83%167.25M | -21.54%152.56M | -15.05%140.85M | 52.68%215.53M | 16.56%140.75M | 20.75%194.44M | 66.33%165.8M | -43.44%141.17M | -17.42%120.76M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- |
| Auditor | Shinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- | -- | Shinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- | -- | Shinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership) | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.